Home >> Signaling Pathways >> Membrane Transporter/Ion Channel >> CFTR

CFTR

CFTR (cystic fibrosis transmembrane conductance regulator) is an ABC transporter-class ion channel that conducts chloride[3] and thiocyanate[4] ions across epithelial cell membranes.

Products for  CFTR

  1. Cat.No. Product Name Information
  2. GC31665 (R)-BPO-27 (R)-BPO-27, the R enantiomer of BPO-27, is a potent, orally active and ATP-competitive CFTR?inhibitor with an?IC50 of 4 nM. (R)-BPO-27  Chemical Structure
  3. GC69812 (R)-Elexacaftor

    (R)-VX-445

    (R)-Elexacaftor is the enantiomer of Elexacaftor (Compound 1) and comes from Compound 37 in patent WO2018107100A1. It is a corrector of cystic fibrosis transmembrane conductance regulator (CFTR), with an EC50 value of 0.29 uM for CFTR dF508.

    (R)-Elexacaftor  Chemical Structure
  4. GC67767 (R)-Olacaftor

    (R)-VX-440

    (R)-Olacaftor  Chemical Structure
  5. GC62513 (R)-Posenacaftor sodium

    (R)-PTI-801 sodium

    (R)-Posenacaftor (R)-PTI-801) sodium is the R enantiomer of Posenacaftor. (R)-Posenacaftor sodium  Chemical Structure
  6. GC70934 (R)-Vanzacaftor (R)-Vanzacaftor ((R)-VX-121) is a regulator of cystic fibrosis transmembrane conduction regulator (CFTR). (R)-Vanzacaftor  Chemical Structure
  7. GC72112 Astressin 2B TFA Astressin 2B TFA is a potent and selective corticotropin-releasing factor receptor 2 (CRF2) antagonist, with the IC50 values of 1.3 nM and > 500 nM for CRF2 and CRF1, respectively. Astressin 2B TFA  Chemical Structure
  8. GC68723 Bamocaftor

    VX-659

    Bamocaftor (VX-659) is a cystic fibrosis transmembrane conductance regulator (CFTR) corrector designed to restore the function of F508del-CFTR protein. Bamocaftor can be used in combination with Tezacaftor and Ivacaftor for research on cystic fibrosis.

    Bamocaftor  Chemical Structure
  9. GC30537 BPO-27 racemate BPO-27 racemate is a potent CFTR inhibitor with an IC50 of 8 nM. BPO-27 racemate  Chemical Structure
  10. GC63976 Cavosonstat

    N91115

    Cavosonstat (N91115) is an orally active S-nitrosoglutathione reductase (GSNOR) inhibitor. Cavosonstat  Chemical Structure
  11. GC35667 CFTR corrector 1

    VX-445

    CFTR corrector 1 (VX-445, Compound 1) is a modulator of cystic fibrosis transmembrane conductance regulator (CFTR). CFTR corrector 1  Chemical Structure
  12. GC34532 CFTR corrector 2 CFTR corrector 2 is a cystic fibrosis transmembrane conductance corrector (CFTR), extracted from patent US20140274933. CFTR corrector 2  Chemical Structure
  13. GC67939 CFTR corrector 4 CFTR corrector 4  Chemical Structure
  14. GC62510 CFTR corrector 6 CFTR corrector 6 is a potent potentiator of Cystic Fibrosis Transmembrane conductance Regulator (CFTR). CFTR corrector 6  Chemical Structure
  15. GC68282 CFTR corrector 8 CFTR corrector 8  Chemical Structure
  16. GC65029 CFTR corrector 9 CFTR corrector 9 (compound 42) is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator. CFTR corrector 9  Chemical Structure
  17. GC14421 CFTRinh-172

    CFTR(inh)172, Cystic Fibrosis Transmembrane Conductance Regulator Inhibitor 172

    CFTR inhibitor, highly potent and selective CFTRinh-172  Chemical Structure
  18. GC67925 Crinecerfont hydrochloride

    SSR-125543 hydrochloride; SSR-125543A

    Crinecerfont hydrochloride  Chemical Structure
  19. GC64121 Dirocaftor Dirocaftor  Chemical Structure
  20. GC68397 Galicaftor

    ABBV-2222; GLPG-2222

    Galicaftor  Chemical Structure
  21. GC19169 GLPG1837

    ABBV-974

    GLPG1837 is a potent and reversible CFTR potentiator, with EC50s of 3 nM and 339 nM for F508del and G551D CFTR, respectively. GLPG1837  Chemical Structure
  22. GC36149 GLPG2451 GLPG2451 is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator, which effectively potentiates low temperature rescued F508del CFTR with an EC50 of 11.1 nM. GLPG2451  Chemical Structure
  23. GC17804 GlyH-101

    GlyH101, Cystic Fibrosis Transmembrane Conductance Regulator Inhibitor II

    CFTR Inhibitor II GlyH-101  Chemical Structure
  24. GC63353 Icenticaftor Icenticaftor (QBW251) is an orally active CFTR channel potentiator, with EC50s of 79 nM and 497 nM for F508del and G551D CFTR, respectively. Icenticaftor  Chemical Structure
  25. GC11229 IOWH-032 CFTR inhibitor IOWH-032  Chemical Structure
  26. GC10296 Ivacaftor (VX-770)

    VX 770

    Ivacaftor (VX-770) (VX-770) is a potent and orally bioavailable CFTR potentiator, targeting G551D-CFTR and F508del-CFTR with EC50s of 100 nM and 25 nM, respectively. Ivacaftor (VX-770)  Chemical Structure
  27. GC12489 Ivacaftor benzenesulfonate

    VX-770 benzenesulfonate;VX 770 benzenesulfonate;VX770 benzenesulfonate;Kalydeco benzenesulfonate

    A CFTR potentiator Ivacaftor benzenesulfonate  Chemical Structure
  28. GC13316 Ivacaftor hydrate

    VX-770 hydrate;VX 770 hydrate;VX770 hydrate;Kalydeco hydrate

    A CFTR potentiator Ivacaftor hydrate  Chemical Structure
  29. GC70634 Ivacaftor-d4 Ivacaftor-d4 (VX-770-d4) is the deuterium labeled-Ivacaftor . Ivacaftor-d4  Chemical Structure
  30. GC64678 K41498 TFA K41498 TFA is a potent and highly selective CRF2?receptor antagonist with Ki?values of 0.66 nM, 0.62 nM and 425 nM for human CRF2α, CRF2β?and CRF1 receptors respectively. K41498 TFA  Chemical Structure
  31. GC14914 KM 11060 Corrects F508del-CFTR trafficking KM 11060  Chemical Structure
  32. GC63479 Navocaftor

    GLPG 3067; ABBV-3067

    Navocaftor (GLPG 3067), as a cystic fibrosis transmembrane regulator (CFTR), is a protein modulator (US 20200377491 Al, example 1). Navocaftor  Chemical Structure
  33. GC68015 NJH-2-057 NJH-2-057  Chemical Structure
  34. GC64358 Olacaftor

    VX-440

    Olacaftor (VX-440) is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator extracted from patent US9782408. Olacaftor  Chemical Structure
  35. GC10288 PG 01 CFTR mutants potentiator PG 01  Chemical Structure
  36. GC62522 Posenacaftor sodium

    PTI-801 sodium

    Posenacaftor (PTI-801) sodium is a cystic fibrosis transmembrane regulator (CFTR) protein modulator that corrects the folding and trafficking of?CFTR?protein. Posenacaftor sodium  Chemical Structure
  37. GC17616 PPQ-102

    CFTR Inhibitor IV, Cystic Fibrosis Transmembrane Conductance Regulator Inhibitor IV

    potent CFTR inhibitor PPQ-102  Chemical Structure
  38. GC12346 PTC124(Ataluren)

    PTC 124;PTC-124

    PTC124(Ataluren) (PTC124) is an orally available CFTR-G542X nonsense allele inhibitor. PTC124(Ataluren)  Chemical Structure
  39. GC34745 PTI-428

    PTI-428

    PTI-428 (PTI-428) is a specific cystic fibrosis transmembrane conductance regulator (CFTR) amplifier. PTI-428  Chemical Structure
  40. GC67789 SRI-37240 SRI-37240  Chemical Structure
  41. GC69942 SRI-41315

    SRI-41315 induces long pauses at termination codons, inhibits premature termination codons (PTCs) associated with permanent and primary human bronchial epithelial cell cystic fibrosis, restores the expression and function of CFTR (cystic fibrosis transmembrane conductance regulator). SRI-41315 inhibits PTCs by reducing the abundance of the termination factor eRF1. SRI-41315 also enhances aminoglycoside-mediated readthrough, resulting in synergistic increases in CFTR activity.

    SRI-41315  Chemical Structure
  42. GC73522 Tezacaftor-d4

    VX-661-d4

    Tezacaftor-d4 (VX-661-d4) is the deuterium-labeled Tezacaftor , a F508del CFTR corrector. Tezacaftor-d4  Chemical Structure
  43. GC72897 UCCF-853 UCCF-853 is a CFTR modulator. UCCF-853  Chemical Structure
  44. GC70933 Vanzacaftor Vanzacaftor is a modulator of cystic fibrosis transmembrane conductance regulator (CFTR) for researching cystic fibrosis. Vanzacaftor  Chemical Structure
  45. GC14920 VX-661

    Tezacaftor

    VX-661 (VX-661) is a second F508del CFTR corrector and help CFTR protein reach the cell surface. VX-661  Chemical Structure
  46. GC15455 VX-809

    VX 809; VX809; Lumacaftor; VRT 826809

    VX-809 (VX-809; VRT 826809) is a CFTR modulator that corrects the folding and trafficking of CFTR protein. VX-809  Chemical Structure

45 Item(s)

per page

Set Descending Direction